A contemporary view of autoimmunity suggests that self-reactivity is a normal phenomenon, in contrast to the classical association between autoimmunity and immunopathology. We have previously demonstrated that monoclonal antibody SCH94.03, a natural autoantibody with polyreactivity towards several purified protein and hapten antigens, promotes central nervous system remyelination when passively transferred to SJL/J mice chronically infected with Theiler's murine encephalomyelitis virus, an established experimental model of multiple sclerosis. In this study we characterized the autoreactivity of SCH94.03 with endogenous mouse tissue using immunoperoxidase and multiple-color immunofluorescence staining techniques on frozen tissue sections. Within the nervous system, SCH94.03 labeled fibrous as-44 :1005-1011, 19%) 
Introduction
Multiple sclerosis (MS) is a chronic inflammatory central nervous system (CNS) demyelinating disease of unknown etiology. Although the immune system is believed to play a pathogenic role in MS, the exact target of the immune response has not been established. The release of normally sequestered CNS antigens during the inflammatory process could lead to an autoimmune response that may be pathogenic, beneficial, or of no physiological consequence. We previously tested the hypothesis that a humoral autoimmune response plays a beneficial rather than a pathogenic role in response to CNS demyelination in SJL/J mice chronically infected with Theiler's murine encephalomyelitis virus (TMEV), an established experimental model of MS (Rodriguez et al., 1987b) . Passive transfer of polyclonal antiserum (Rodriguez et al., 1987a) , purified polyclonal immunoglobulin (Rodriguez and Lennon, 1990) , or monoclonal antibodies (Miller et al., 1994) ' Correspondence to: Dr. Moses Rodriguez, Dept. of Immunology, Mayo Clinic, 200 First St. SW, Rochester, MN 55905. trocytes, ependymal cells, ganglion satellite cells, and a subpopulation of microglia, oligodendrocytes, and peripheral nervous system neurons. Outside the nervous system, SCH94.03 labeled gastrointestinal tract smooth muscle and luminal epithelium, erythrocytes, and interdigitating dendritic cells in peripheral lymphoid organs. These data indicate that SCH94.03 is a multi-organ reactive autoantibody and support the hypothesis that autoantibodies can have a beneficial rather than a pathogenic function in central nervous system demyelinating diseases. (JHisrochem Cytochem SJL/J mice injected with normal syngeneic homogenized spinal cord (SCH) markedly enhanced CNS remyelination in chronically infected mice. We have previously demonstrated that one therapeutic monoclonal antibody (MAb), designated SCH94.03, is an IgM natural autoantibody encoded by germline immunoglobulin genes with reactivity towards several purified proteins and chemical haptens in solid-phase assays . However, this reactivity with purified antigens may not have identified the complete autoreactive potential of SCH94.03. Therefore, in this report we characterize SCH94.03 reactivity towards endogenous mouse tissue using immunohistochemistry, and show that SCH94.03 has broad reactivity both within and outside the CNS.
Materials and Methods
Animals. SJL/J mice were purchased from the Jackson Laboratory (Bar Harbor, ME). For normal mouse tissue, 5-month-old mice were used. For infected mouse tissue, 4-6-week-old mice were injected intracerebrally with 2 x 10' plaque-forming units of the Daniel's strain of TMEV. Infected mice were used at 8 months after infection, at which time they showed both pathological and clinical signs of chronic demyelination (Miller et al., 1994) . Mice were sacrificed by IP pentobarbital injection (0.25 mglmouse). Adult Harlan Sprague-Dawley (HSD) rats were purchased from Holtzman MILLER, NJENGA, PARISI, RODRIGUEZ Laboratory Animals (Madison, WI), and bred at the Mayo Clinic. For young rat tissue, 30-day-old rats were used. Rats were sacrificed by ether anesthesia and decapitation. Handling of all animals conformed to both the National Institutes of Health and the Mayo Clinic institutional guidelines.
Reagents. Hybridoma SCH94.03 secretes a mouse IgM, monoclonal autoantibody and was produced from the splenocytes of an uninfected SJL/J mouse injected with normal syngeneic SCH as described (Miller et al., 1994) . Control IgM was obtained from the myeloma MOPClO4E (Sigma; St Louis, MO). Polyclonal rabbit antibodies against glial fibrillary acidic protein (GFAP) and myelin basic protein (MBP) (Dako; Carpinteria, CA) were used to localize astrocytes and oligodendrocytes, respectively, whereas antibodies against neurofilament 200 (Sigma) and neuron-specific enolase (Zymed Laboratories; South San Francisco, CA) detected neurons. Microglia were detected with isolectin B4 from Bandeiraea simphyolza (Sigma) and a mouse anti-I-A, MRC OX-6 from Serotec (Oxford, UK). All secondary immunoglobulin reagents were from Jackson Immunoresearch (West Grove, PA).
Frozen Section Immunostaining. Freshly isolated mouse, rat, and human autopsy tissues were flash-frozen in isopentane chilled in liquid nitrogen and were stored in liquid nitrogen until sectioning. Frozen sections 10 pm thick were immunostained using immunoperoxidase and immunofluorescent procedures as previously described (Miller et al., 1994) . We first investigated the effect of different fixatives on the immunohistochemical staining of tissue sections with MAb SCH94.03. Fixation in 95% ethanol-5% glacial acetic acid eliminated SCH94.03 immunoreactivity with CNS tis-sue sections, whereas 4% paraformaldehyde-1% glutaraldehyde fixation followed by 150 mM ethanolamine incubation resulted in diffuse staining of CNS tissue. However, tissue sections that were either unfixed or fixed in acetone showed intense SCH94.03 staining of unique cells and structures in individual tissues. All results reported here were obtained using either unfixed or acetone-fixed frozen tissue sections, and refer to cells or structures that showed prominent reactivity with SCH94.03 above the minimal background staining seen with a control IgM. For two-color immunofluorescence, both primary antibodies were incubated simultaneously. We excited fluorescein ( F I E ) and Texas Red (TR) fluorochromes with an Hg lamp attached to a Zeiss microscope equipped with filter sets to visualize F I X [450-490-nm bandpass (BP) exciter filter. 510-nm dichroic beam splitter (FT) filter, 520-nm longpass (LP) barrier filter] and TR (BP546112-nm exciter, FT480-nm dichroic. LP590-nm barrier) florescence individually.
Results

SCH94.03 Immunoreactivity in Nervous System Tissue
Spinal cord was used as the immunogen and initial screening antigen to select SCH94.03 (Miller et al., 1994) . Therefore, we examined whether SCH94.03 labeled cells in frozen mouse CNS tissue sections ( Figure 1 ). We had previously demonstrated that SCH94.03 . I labels cells with morphological features of glial cells in CNS tissue sections (Miller et al., 1994) . Two-color immunofluorescence identified these glial cells as astrocytes, as SCH94.03 immunoreactivity co-localized with immunoreactivity for the astrocyte-specific intermediate filament protein GFAP ( Figures 1A and 1B ). SCH94.03 labeled astrocytes throughout the CNS in both white and gray matter. The astrocytes labeled by SCH94.03 had the morphology of fibrous astrocytes and were seen most distinctively in subependymal zones and in white matter tracts such as the optic nerve ( Figure  IC) and corpus callosum. Prominent fibrous astrocyte reactivity of SCH94.03 was also noted in cerebellar sections from young rats (Figure 1D ).
There were other CNS cells that labeled with SCH94.03, including ependymal cells lining the ventricular system (Figure 2A ) and the astrocyte-related Muller cells in the retina ( Figure 2C ). Most microglia/macrophages and oligodendrocytes were not reactive to SCH94.03. However, two-color immunofluorescence Bandeirueu rimplicifolia isolectin B4 or MRC OX-6 (anti-I-A) for microglia/ macrophages and MBP for oligodendrocytes clearly demonstrated a small subpopulation of microglialmacrophages and oligodendrocytes that labeled with SCH94.03 (data not shown). Because of inadequacies of available markers for oligodendrocytes and resting microglia for use in immunohistochemistry, we were unable to more specifically evaluate the proportions of oligodendrocytes and microglia labeled by SCH94.03. SCH94.03 did not label cells with the distribution or morphology of CNS neurons, nor did SCH94.03 staining co-localize with either neurofilament or neuron specific enolase, indicating that neurons were not labeled with SCH94.03 in unfixed or acetone-fixed frozen CNS tissue sections.
Within the PNS, SCH94.03 labeled satellite cells and a subpopulation of peripheral ganglion neurons ( Figure 2D ). Satellite cells are developmentally and functionally related to Schwann cells. They surround the neuronal perikaryon and from a neuronal sheath in PNS ganglia ( Figure 2D , inset), similar to some perineuronal astrocytes in the CNS (Peters et al., 1991) . The identity of the neuronal subpopulation stained by SCH94.03 is unknown. SCH94.03 also labeled longitudinal structures in peripheral nerve, which were most likely axonal processes of the neurons stained by SCH94.03, as continuity with the neuronal perikaryon was seen ( Figure 2E ). The differential staining pattern of SCH94.03 on PNS and CNS tissue was best seen at a junctional region, such as the preganglionic trigeminal nerve ( Figure 2F ). There was a clear demarcation where CNS astrocytes, which labeled intensely with SCH94.03, formed the glial limitans. In peripheral muscle tissue, SCH94.03 labeled interfascicular neural bundles in skeletal muscle and the intermuscular neural plexi in gastrointestinal smooth muscle.
SCH94.03 Immunoreactivity in CNS Tissue from Cbronicalljl Infected Mice
We used mice chronically infected with TMEV to test the therapeutic effectiveness of SCH94.03 (Miller et al., 1994) . Although SCH94.03 does not react with TMEV proteins (Miller et al., 1994) , we investigated whether chronic infection with TMEV altered the immunoreactivity of SCH94.03 in CNS tissue (Figure 3) . Chronic infection with TMEV did not alter the specificity of SCH94.03 CNS tissue immunoreactivity. However, the extent and intensity of SCH94.03 staining were greater in spinal cord lesions where astrocyte hypertrophy was seen ( Figure 3A ). SGH94.03 labeled some intralesional cells whose vacuolated morphology suggested that they were macrophages ( Figure 3A, inset) . Multiple-color immunofluorescent staining identified these cells as activated microglial/macrophages, as SCH94.03 immunostaining co-localized with Bandeiraea simplicifolia isolectin B4 and I-A reactivity (data not shown). We investigated whether the microglialmacrophages labeled with SCH94.03 were the result of engulfed astrocytic debris characteristic of phagocytic function. By double immunofluorescence for astrocytes (GFAP) and macrophages (B4 lectin or 1-A), there was no co-localization. Therefore, the subpopulation of macrophages/microglia positive for SCH94.03 were not the result of inaccurate identification from labeling astrocytic debris.
SCH94.03 Immunoreactivity in Non-nervous System Tissue
Although SCH94.03 was generated using SCH as both the induction and the screening antigen (Miller et al., 1994) . SCH94.03 immunoreactivity was also seen with tissues and structures outside the nervous system. Table 1 lists the cells and structures that showed SCH94.03 immunoreactivity. The most prominent immunoreactivity of SCH94.03 outside the nervous system was in gastrointestinal mucosal and circular smooth muscle layers ( Figure 4A ). SCH94.03 also labeled the gastrointestinal intermuscular plexi, fibers in the lamina propria, and the intestine luminal epithelium. In all tissues examined, SCH94.03 labeled residual erythrocytes (Figure 4C ) and erythrocyte debris, consistent with its previously identified reactivity toward both spectrin and hemoglobin . In peripheral lymphoid organs, SCH94.03 labeled cells with the reticular morphological appearance of dendritic cells ( Figure 4D ). Multicolor immunofluorescence staining identified these cells as major histocompatibility complex (MHC) Class 11-positive interdigitating dendritic cells (Miller et al., 1996) . These data indicated that SCH94.03 reacted with antigen(s) that was expressed both within and outside the nervous system, and demonstrated that SCH94.03 was a multi-organ reactive autoantibody.
Discussion
Monoclonal autoantibody SCH94.03 was selected on the basis of its therapeutic effect, rather than of its antigen specificity (Miller et al., 1994) . We sought to characterize the immunoreactivity of SCH94.03 in an attempt to identify potential mechanisms of action for this therapeutic monoclonal autoantibody. We have previously proposed two general mechanisms of autoantibody-mediated remyelination . The first mechanism is a direct effect, in which autoantibodies stimulate oligodendrocytes or cells that secrete factors necessary for oligodendrocyte survival or differentiation. The astrocyte reactivity of SCH94.03 is consistent with this hypothesis, as astrocytes secrete a number of growth and differentiation factors utilized by oligodendrocytes (deVellis, 1993) . The second mechanism is based on an indirect effect, in which autoantibodies inhibit a pathogenic immune response, thereby al-P . '-F. . Figure 2 . lmmunoperoxidase staining of frozen nervous system tissue sections with monoclonal autoantibody SCH94.03. (A) Ependyma (e) and periventricular fibrous astrocytes (p) in mouse cerebrum stained with SCH94.03. ( 6 ) Same field as A stained with a control IgM. (C) Muller cell processes in mouse retina (r) stained with SCH94.03. Note the absence of photoreceptor, outer nuclear, and outer plexiform layers, which is a characteristic of the retinal degeneration seen in SJUJ mice (Sidman and Green, 1965 Results are from immunoperoxidace staining of frozen normal adult mouse tis. sue sections either unfixed or fixed with acetone. unless otherwise indicated. Similar rcwlts for a l l tissues were ohtaincd with tissue sections from young rats and for CNS and kidney sections from human autopsy tissues.
Cells and structures showed concistent. prominent reactivity with SCH04.03 above background staining with a control IgM. 6 Cerebrum. cerebellum. brainstem. spinal cord. optic nerve. and rye. "Sciatic nerve. trigeminal ganglia and adlacent nerve. and spinal ganglia. ' Stomach. small and large intestine.
' Rrcause o f hackground problems in mouse glomeruli with the secondary detection reagent. the mesangial cell reactivity was iontluded primarily from human and rat kidney sections. lowing a normal physiological repair response to predominate. The lymphoid dendritic cell, microglial, and astrocyte reactivity of SCH94.03 supports the immunomodulatory mechanism. Although dendritic cells and microglia function as professional antigenpresenting cells, astrocytes do not normally serve this function. However, astrocytes can upregulate MHC Class I and I11 expression when activated during inflammatory responses in the CNS (Lassmann et al., 1991) , and have been shown to present antigens to pathogenic T-cells in vitro (Fontana et al., 1984) . Interestingly, we observed an increase in SCH94.03 reactivity in inflammatory spinal cord lesions of chronically infected mice, suggesting that SCH94.03 recognizes an antigen upregulated during inflammation. The broad reactivity of SCH94.03 both within and outside the CNS in structures with no readily apparent antigenic connection is consistent with its polyreactivity towards several distinct purified proteins and haptens in solid-phase immunoassays . Although further biochemical and molecular studies will be required to identify the precise antigens responsible for the immunohistochemical reactivity of SCH94.03, we are cautious about drawing a conclusion concerning the therapeutic effect of SCH94.03 solely on the basis of antigenic characterization. There are several potential problems with using a standard biochemical approach to characterize the antigenic specificity of polyreactive MAbs (Ghosh and Campbell. 1986 ). For example, Asakura et al. (1996) demonstrated SCH94.03 reactivity with multiple protein bands on Western blots of glial cell lysates, which prevented definitive identification of the surface antigen responsible for the potential therapeutic effect of SCH94.03 on oligodendrocytes. Preliminary studies using Western blots of heterogeneous tissue lysates has also shown SCH94.03 reactivity with multiple protein bands (D. Miller and M. Rodriguez, unpublished data) . These observations indicate that elucidation of the relevant specificity and the therapeutic effect of SCH94.03 must be guided by both im-munochemical antigenic characterization and in vivo functional analyses.
The data presented here demonstrate that SCH94.03 is a multiorgan reactive autoantibody. We have previously shown that SCH94.03 is a natural autoantibody, with polyreactivity towards several purified proteins and haptens . Natural autoantibodies represent a ubiquitous population of selfreactive antibodies whose intrinsic physiological function is unknown (Avrameas and Ternynck, 1993) . They are frequently IgMs encoded by germline immunoglobulin genes and are polyreactive with purified antigens. as demonstrated by solid-phase assays. Similar to polyreactive natural autoantibodies, multi-organ reactive IgM MAbs have been derived from both normal mice (Hartman et al., 1989; Prabhaker et al., 1984) and humans (Allaway et al., 1988; Garzelli et al., 1984) . Hartman et al. (1989) found that seven of eight IgM MAbs isolated from unimmunized Balb/c mice that were both polyreactive with purified antigens and encoded by germline immunoglobulin JH and J K gene segments were also multi-organ reactive by immunohistochemistry. The data presented in this report, together with our previous demonstration that SCH94.03 is a natural autoantibody . further support the hypothesis that multi-organ reactivity is a characteristic of some natural autoantibodies.
The function of multi-organ reactive autoantibodies is unknown. A pathogenic role has been suggested on the basis of observations that the serum of patients with an autoimmune polyendocrinopathy syndrome contains multi-organ reactive autoantibodies (Mirakian et al. 1982 ; Battazzo et al., 1974 ; Irvine et al., 1970) . The serum from mice with a reovirus Type I-induced polyendocrine disease also contains multi-organ reactive autoantibodies Onodera et al., 1981) . In addition, Satoh et al. (1983) produced several hybridomas secreting monoclonal multi-organ reactive autoantibodies from peripheral blood lymphocytes of patients with insulin-dependent diabetes mellitus who also had additional autoimmune abnormalities. However, subsequent studies have shown that multi-organ reactive autoantibodies are part of the normal B-cell repertoire (Hartman et al., 1989; Allaway et al. 1988 ; Garzelli et al., 1984; Prabhaker et al., 1984) and can be found in the serum of normal individuals (Uchigata et al., 1987) , indicating that these autoantibodies are not always pathogenic. The observation that SCH94.03 promotes CNS remyelination rather than inducing demyelination indicates that some multi-organ reactive autoantibodies have a beneficial physiological function.
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